Fungal Resistance Mechanism in Candida tropicalis

Certain fungal pathogens can develop resistance to antifungal medications through genetic changes. Research has identified a specific mechanism involving alterations in chromosomes.

Chromosome Alterations and Drug Resistance

Candida tropicalis is a fungal species known to employ chromosome alterations as a strategy to overcome common antifungal drugs, including fluconazole and voriconazole.

• Mechanism: This species can acquire extra copies of entire chromosomes (aneuploidy) or specific chromosome segments.
• Drug Resistance: These alterations often lead to increased expression of genes involved in drug resistance, such as those encoding drug efflux pumps (like CDR and MDR genes) or alterations in the target enzyme (like Erg11p for azoles).
• Impact: The amplification or increased activity of these resistance factors significantly reduces the effectiveness of fluconazole and voriconazole, allowing the fungus to survive and proliferate in the presence of these drugs.

This ability to adapt genetically, particularly through chromosomal changes, highlights the challenge in treating infections caused by resistant strains of Candida tropicalis.